ALDO+ Testing Platform
Screening for Primary Aldosteronism and secondary hypertension causes
Key Facts
About aTENSION.life
aTENSION.life is on a mission to redefine hypertension care through precision diagnostics and personalized treatment. Their core innovation is the ALDO+ platform, which uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) to directly measure key hypertension hormones (Angiotensin I, Angiotensin II, Aldosterone) from a single blood sample, enabling accurate screening for secondary hypertension causes like primary aldosteronism. The company's unique Prep 'n' Ship™ operational model bridges the gap between labs with and without mass spectrometry capabilities, creating a scalable network for advanced hypertension diagnostics. By addressing the critical under-diagnosis of secondary hypertension, aTENSION aims to improve patient outcomes and reduce cardiovascular risks through targeted therapy.
View full company profile